Change the Future for Your Patients and Your Practice

Our collection of customer success stories offers a look at some of the benefits of integrating dark adaptation testing into your patient care arsenal. Learn how your fellow eye care professionals utilize AdaptDx^® technology as they work towards improved outcomes for their AMD patients as well as their practice.

E-Book: Practical Implementation of Dark Adaptation in Optometric Practice

Going beyond explaining why dark adaptation is so important in optometric practice. Having already established the reasons why functional testing is essential, this year’s report outlines the practical strategies for how to make routine testing a reality in your own eye care practice.

5 Tips for Recommending Smoking Cessation Programs

Dr. Timothy Earley shares tips on how to talk to patients about smoking cessation, the biggest modifiable risk factor for AMD, and how to motivate them to quit.

Our interactive Virtual Exhibit allows you to meet the newest member of our team – Theia, the on-board technician for the AdaptDx Pro headset dark adaptometer. Theia will welcome you to the booth as you learn how tackling AMD can benefit your practice.

Explore the exhibit at your leisure – without any sales pressure – and see this amazing technology for yourself. When you are ready to learn more, just enter your ZIP Code into the laptop in the booth to find your Regional Sales Executive.

Before drusen are visible, an invisible layer of cholesterol builds up between the pigmented layer of the retina (RPE) and the elastic layer of Bruch’s membrane. These cholesterol deposits — basal laminar (BLamD) and basal linear (BLinD) — cause oxidative stress and inflammation, hindering nutrient transportation to photoreceptor cells. As photoreceptor cells die, it becomes harder for the eyes to adjust to the darkness, and night vision declines. This dark adaptation impairment is the first sign of AMD.

The cholesterol deposits grow over time. Where they become sufficiently thickened, the lesion becomes clinically detectable as a druse. The first visible druse caused by AMD is just the tip of the iceberg of these lesions.

Research has shown that impaired dark adaptation function can be detected at least three years before drusen are clinically evident, allowing for earlier diagnosis, treatment, and monitoring of AMD.

Find the answers to frequently asked questions about AMD, dark adaptation, and AdaptDx Pro testing.